Accolade (NASDAQ:ACCD) announced its quarterly earnings data on Wednesday. The company reported ($0.32) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.35) by $0.03, MarketWatch Earnings reports. The company had revenue of $38.44 million for the quarter, compared to the consensus estimate of $36.20 million. The firm’s quarterly revenue was up 29.7% compared to the same quarter last year.
ACCD stock opened at $49.67 on Friday. The firm’s 50 day simple moving average is $50.48. Accolade has a 52-week low of $28.68 and a 52-week high of $65.25.
Several analysts recently issued reports on the company. SVB Leerink raised their target price on Accolade from $44.00 to $53.00 and gave the stock a “market perform” rating in a research note on Friday. Piper Sandler raised their target price on Accolade from $55.00 to $57.00 and gave the stock an “overweight” rating in a research note on Friday. Bank of America lifted their price objective on Accolade from $45.00 to $51.00 and gave the company a “buy” rating in a research report on Thursday, October 15th. Credit Suisse Group lifted their price objective on Accolade from $42.00 to $45.00 and gave the company a “neutral” rating in a research report on Friday. Finally, Robert W. Baird lifted their price objective on Accolade from $45.00 to $50.00 and gave the company an “outperform” rating in a research report on Friday. Three research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. Accolade has a consensus rating of “Buy” and a consensus target price of $50.08.
Accolade Company Profile
Accolade, Inc develops and provides technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and with multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists.
See Also: What is total return in investing?
Receive News & Ratings for Accolade Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accolade and related companies with MarketBeat.com's FREE daily email newsletter.